The Latest Breaking News on Pharma

Biotech stock Kiniksa soared after first-quarter results on April 29. Shares are near a buy point of 28.15.

Protagonist Therapeutics is taking aim directly at Eli Lilly's obesity treatment with a newly announced drug that uses the same mechanism.

A report found that of 361 systems installed since 2019, 166 (46%) were inoperable at some point, sometimes for as long as 344 days, resulting in more than 400,000 hours of downtime

Medicine shortages are causing unprecedented issues for patients, Community Pharmacy England said.

Gilead Sciences shares rose Friday after the Supreme Court tossed out a challenge that would have impacted HIV PrEP drugs.

President Donald Trump, ever the negotiator, is angling to lower drug prices through his Most Favored Nation policy. But will it work? And will biotech stocks take a hit?

The world drug market has never been so globalised, active and diverse, according to the United Nations – which marks International Day Against Drug Abuse and Illicit Trafficking on Thursday. RFI takes a look at the latest trends, from the explosion of cocaine to shifting routes and new synthetic drugs.

Biogen said Wednesday its experimental treatment helped children with SMA even after they received an approved gene therapy from Novartis.

Plaintiff says company’s bid to exit bankruptcy omits US government plan to seize $225m that should go to victims

Louisiana accused pharmaceutical giant CVS of using its dominant market position to abuse customer information, drive up drug costs and unfairly undermine independent pharmacies

US health secretary faced hours of questioning over budget cuts and accusations he lied to senators